DISCLOSEDQuarterly
Renaissance Technologies
Moonlake Immunotherapeutics · NASDAQ
276,772 sh · $5.2M
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Moonlake Immunotherapeutics · NASDAQ
276,772 sh · $5.2M
Two Sigma Investments
Moonlake Immunotherapeutics · NASDAQ
1,122,312 sh · $20.9M
BlackRock
Moonlake Immunotherapeutics · NASDAQ
392,024 sh · $17.2M